Your search for tofacitinib returned 4 results

Early experimental study shows promise; more research needed

Researchers report that a drug for rheumatoid arthritis may be a promising treatment for vitiligo.

For patients with rheumatoid arthritis (RA), moderate changes in lipids are observed after treatment with tocilizumab or tofacitinib.

Tofacitinib is superior to methotrexate in treating rheumatoid arthritis, but increased side effects were seen with tofacitinib, including development of herpes zoster.